中医药
2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
医学
机制(生物学)
疾病
传统医学
中草药
传染病(医学专业)
冠状病毒
病毒学
生物信息学
重症监护医学
生物
替代医学
病理
哲学
爆发
认识论
作者
Lin Li,Yuzheng Wu,Jiabao Wang,Huimin Yan,Jia Lu,Yu Wang,Boli Zhang,Junhua Zhang,Jian Yang,Xiaoying Wang,Min Zhang,Yue Li,Lin Miao,Han Zhang
出处
期刊:Engineering
[Elsevier BV]
日期:2021-10-28
卷期号:19: 139-152
被引量:30
标识
DOI:10.1016/j.eng.2021.08.020
摘要
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacological mechanisms underlying this success remain unclear. Hence, the aim of this review is to combine pharmacological assays based on the theory of TCM in order to elucidate the potential signaling pathways, targets, active compounds, and formulas of herbs that are involved in the TCM treatment of COVID-19, which exhibits combatting viral infections, immune regulation, and amelioration of lung injury and fibrosis. Extensive reports on target screening are elucidated using virtual prediction via docking analysis or network pharmacology based on existing data. The results of these reports indicate that an intricate regulatory mechanism is involved in the pathogenesis of COVID-19. Therefore, more pharmacological research on the natural herbs used in TCM should be conducted in order to determine the association between TCM and COVID-19 and account for the observed therapeutic effects of TCM against COVID-19.
科研通智能强力驱动
Strongly Powered by AbleSci AI